Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Pearl Toh, 5 days ago
Obeticholic acid significantly improves fibrosis and disease activity in patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease currently with no approved therapy, according to an interim analysis of the landmark REGENERATE* study.
6 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.

Acceptance may improve quality of life, mental health following spinal cord injury

20 Nov 2019
New technology allows spinal-cord-injury patients to move their leg muscles and feel pain once again

Acceptance is an important psychological resource that healthcare professionals can tap to improve quality of life (QoL) and mental health in individuals living with spinal cord injury (SCI), results of a recent systematic review suggest.

Forty-one studies met the eligibility criteria. The quality of quantitative studies included was mostly ‘fair’ (n=17), followed by ‘good’ (n=13) and poor (n=9).

Greater acceptance showed a consistent correlation with higher global and psychological QoL, life satisfaction, sense of well-being, mental health, and with lower levels of depression and anxiety. Evidence regarding social QoL and post-traumatic stress disorder were inconsistent. In general, however, acceptance did not correlate with adjustment outcomes further than 2 years into the future.

“Healthcare professionals may regard acceptance as a psychological resource they can aim to support in improving QoL and mental health following SCI,” the authors said.

A systematic search was conducted in five databases, namely PubMed, PsycINFO, Embase, Web of Science and Scopus. Studies with available findings on the association between acceptance and QoL, mental health outcomes, or both in an SCI population aged 16 years were included. The investigators included only peer-reviewed original quantitative and qualitative studies.

Two researchers independently performed the screening, quality assessment and extraction of data. Findings were then tabulated and synthesized by outcome.

“A range of methodological and conceptual limitations were present in the research,” the investigators said. “Future studies should prioritize longitudinal designs, consider dyadic effects, explore subjective meaning(s) of acceptance and investigate the effectiveness of therapeutic approaches that stimulate the acceptance process.”

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Pearl Toh, 5 days ago
Obeticholic acid significantly improves fibrosis and disease activity in patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease currently with no approved therapy, according to an interim analysis of the landmark REGENERATE* study.
6 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.